Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=7
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=7
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=7
PubPharm (60.420)
61
A Study to Assess if Fremanezumab is Effective in Preventing Migraine in Patients with Major Depressive Disorder : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Extension to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients with Major Depressive Disorder - UNITE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
62
Investigation to Efficacy and Safety of CC-90001 in patients with Idiopathic Pulmonary Fibrosis : A Phase 2, 24-Week Randomized, Double-blind, Placebo-ControlledMulticenter Study, With an 80-Week Active Treatment Extension, toEvaluate the Efficacy and Safety of CC-90001 in Subjects with IdiopathicPulmonary Fibrosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
63
Study to evaluate the efficacy, safety, tolerability and the extent to which the study drug is distributed in the body of multiple doses of QR-110 in subjects with LCA10 compared to a sham procedure. The study will be double-masked, randomized and controlled which means that both patients and study staff will not know and cannot influence who receives which treatment (study drug of sham). : A Double-Masked, Randomized, Controlled, Multiple-Dose Study to Evaluate the Efficacy, Safety, Tolerability and Systemic Exposure of QR-110 in Subjects with Leber’s Congenital Amaurosis (LCA) due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene - Illuminate
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
64
Study of efficacy and safety of canakinumab as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) completely resected non-small cell lung cancer : A phase III, multicenter, randomized, double blind, placebo-controlled study evaluating the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) completely resected (R0) non-small cell lung cancer (NSCLC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
65
A Study of Superoxide Dismutase Mimetic GC4419 for the reduction of Severe Oral Mucositis (SOM) in patients with head and neck cancer : An Open Label Multi-Center Study of the Effects of Superoxide Dismutase Mimetic GC4419 when Administered to Reduce the Incidence and Severity of Severe Oral Mucositis (SOM) Associated with Chemoradiotherapy for Locally Advanced, NonMetastatic Head and Neck Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
66
A study to evaluate the safety, tolerability and efficacy of AUP1602-C product for diabetic foot ulcers : A Phase 1/2A clinical study to evaluate the safety, tolerability and efficacy of single and repeated doses of AUP1602-C as topical treatment of diabetic foot ulcers
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
67
A clinical study of Pembrolizumab plus axitinib vs. sunitinib in advanced kidney cancer : A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-426) - Pembrolizumab plus axitinib vs. sunitinib monotherapy in advanced/metastatic renal cell carcinoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
68
A long-term extension study of a new investigational medicinal product for the treatment of Duchenne Muscular Dystrophy patients : Long-term, Open-label Extension Study for Patients with Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen - N/A
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
69
A Clinical study to assess the safety and effectiveness of ARN-509 in men with Castration-Resistant Prostate Cancer (prostate cancer not responsive to castration treatment) : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer - SPARTAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
70
A phase 2, multicenter, international, open-label, safety and efficacy study of INCB050465 in patients with relapsed or refractory diffuse large B-cell lymphoma. : A Phase 2, Multicenter, International, Open-Label, Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma - CITADEL-202
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
2
3
4
5
6
7
8
9
10
11
12
Nächster »
[6042]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
60.420
Aufsätze
60.420
E-Artikel
60.420
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
60.420
610
60.420
Recruitment Status: Authorised-recruitment may ...
60.420
Study Type: Interventional
23.556
Phase: Phase 3
15.068
Phase: Phase 2
4.508
Phase: Phase 4
3.278
Phase: Phase 1
152
Medical Condition: Multiple Myeloma MedDRA vers...
122
Medical Condition: Moderately to Severely Activ...
114
Medical Condition: Diabetes Mellitus, Type 2 Me...
88
Medical Condition: Atopic Dermatitis MedDRA ver...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
86
Medical Condition: Ulcerative Colitis MedDRA ve...
84
Medical Condition: Cystic Fibrosis MedDRA versi...
76
Medical Condition: Asthma MedDRA version: 20.0L...
68
Medical Condition: Myelofibrosis MedDRA version...
66
Medical Condition: Mild cognitive impairment (M...
64
Medical Condition: Chronic Obstructive Pulmonar...
64
Medical Condition: Moderately to Severely Activ...
64
Medical Condition: Multiple myeloma MedDRA vers...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
35.522
2020-
24.898
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
56.722
Englisch
1.244
Unbestimmt
1.058
Französisch
794
Spanisch
162
Finnisch
124
Deutsch
70
Schwedisch
58
Niederländisch
58
Italienisch
44
Dänisch
26
Galizisch
12
Ungarisch
10
Norwegisch
8
Tschechisch
6
Latein
4
Isländisch
2
Estnisch
2
Frisian
2
Hausa
2
Indonesisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...